AdvanSix Inc. (ASIX) Business Metric Overview - Stocknear

AdvanSix Inc.

NYSE: ASIX · Real-Time Price · USD
21.04
0.33 (1.59%)
At close: Sep 04, 2025, 3:59 PM
21.04
0.00%
After-hours: Sep 04, 2025, 06:15 PM EDT

AdvanSix Revenue Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021
Caprolactam Revenue 66.42M 67.43M 57.19M 76.34M 81.3M 61.48M 82.51M 68.79M 74.68M 72.39M 71.87M 90.82M 87.17M 70M 235.87M 80.27M
Caprolactam Revenue Growth -1.49% +17.92% -25.09% -6.11% +32.25% -25.49% +19.94% -7.88% +3.17% +0.72% -20.86% +4.19% +24.52% -70.32% +193.86% n/a
Chemical Intermediates Revenue 107.33M 93.75M 79.13M 120.49M 129.28M 105.7M 118.29M 83.46M 121.36M 114.56M 101.95M 115.27M 158.61M 135.69M 413.58M 130.92M
Chemical Intermediates Revenue Growth +14.48% +18.48% -34.33% -6.80% +22.31% -10.64% +41.73% -31.23% +5.94% +12.38% -11.56% -27.33% +16.89% -67.19% +215.91% n/a
Nylon Resins Revenue 79.5M 88.37M 67.2M 93.69M 103.22M 84.39M 78.25M 86.06M 92.95M 99.37M 93.51M 141.02M 132.1M 118.61M 300.79M 122.11M
Nylon Resins Revenue Growth -10.03% +31.50% -28.27% -9.23% +22.31% +7.84% -9.07% -7.42% -6.46% +6.27% -33.69% +6.75% +11.38% -60.57% +146.32% n/a

Revenue by Geography

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
Non-Us Revenue 51.35M 57.34M 50.43M 58.29M 51.62M 52.24M 85.51M 58.05M 60.33M 79.62M 72.15M 85.32M 89.58M 76.06M 80.86M 81.28M 64.27M 75.71M 73.17M 64.85M 56.71M 72.27M 60.58M 55.66M 57.25M 61.84M 62.6M 57.96M 61.59M
Non-Us Revenue Growth -10.45% +13.71% -13.48% +12.93% -1.19% -38.90% +47.30% -3.78% -24.22% +10.36% -15.44% -4.75% +17.78% -5.94% -0.53% +26.47% -15.11% +3.47% +12.84% +14.35% -21.53% +19.30% +8.83% -2.78% -7.43% -1.21% +8.01% -5.89% n/a
United States Revenue 358.67M 320.45M 278.63M 339.89M 401.86M 284.59M 296.7M 264.86M 367.61M 320.93M 331.92M 393.45M 494.15M 403.02M 343.21M 365.21M 373.41M 300.67M 267.18M 217.06M 176.31M 230.44M 250.06M 289.55M 257.64M 324.81M 306.05M 342.5M 297.65M
United States Revenue Growth +11.93% +15.01% -18.02% -15.42% +41.21% -4.08% +12.02% -27.95% +14.55% -3.31% -15.64% -20.38% +22.61% +17.43% -6.02% -2.20% +24.19% +12.53% +23.09% +23.11% -23.49% -7.84% -13.64% +12.39% -20.68% +6.13% -10.64% +15.07% n/a

Operating Expense Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 25.42M 23.41M 21.73M 24.27M 24.43M 23.59M 24.83M 21.59M 24.01M 25.11M 22.63M 23.07M 20.84M 21.21M 20.87M 21.12M 21.68M 19.31M 20.04M 16.18M 17.91M 16.74M 16.69M 19.26M 20.01M 19.41M 26.04M 18.06M 17.92M 19.21M 18.79M 19.09M 18.13M 16.81M 19.8M 11.7M 10.88M 11.38M 13.19M 14.61M 13.21M 11.39M
Selling, General, and Administrative Revenue Growth +8.57% +7.71% -10.43% -0.68% +3.55% -4.97% +15.02% -10.10% -4.39% +10.99% -1.91% +10.69% -1.74% +1.61% -1.17% -2.59% +12.30% -3.66% +23.89% -9.68% +7.00% +0.29% -13.34% -3.74% +3.07% -25.43% +44.18% +0.77% -6.74% +2.24% -1.54% +5.27% +7.88% -15.14% +69.34% +7.53% -4.42% -13.76% -9.69% +10.61% +15.99% n/a
Research and Development Revenue n/a n/a 8.8M n/a n/a n/a 9.8M n/a n/a n/a 12.5M n/a n/a n/a 14M n/a n/a n/a 11.8M n/a n/a n/a 13.9M n/a n/a n/a 14.8M n/a n/a n/a 12.9M n/a n/a n/a 13.76M n/a n/a n/a 12.81M n/a n/a n/a
Research and Development Revenue Growth n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a n/a